Acceleron Pharma Inc. EPS - Earnings per Share 2013-2021 | XLRN
Acceleron Pharma Inc. eps - earnings per share from 2013 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Acceleron Pharma Inc. Annual EPS |
| 2020 |
$-2.92 |
| 2019 |
$-2.38 |
| 2018 |
$-2.59 |
| 2017 |
$-2.68 |
| 2016 |
$-1.52 |
| 2015 |
$-1.92 |
| 2014 |
$-1.63 |
| 2013 |
$-4.15 |
| 2012 |
$-24.84 |
| 2011 |
$0.78 |
| Acceleron Pharma Inc. Quarterly EPS |
| 2021-09-30 |
$-1.16 |
| 2021-06-30 |
$-1.05 |
| 2021-03-31 |
$-1.05 |
| 2020-12-31 |
$-0.97 |
| 2020-09-30 |
$-0.66 |
| 2020-06-30 |
$-0.34 |
| 2020-03-31 |
$-0.95 |
| 2019-12-31 |
$-0.44 |
| 2019-09-30 |
$-0.86 |
| 2019-06-30 |
$-0.34 |
| 2019-03-31 |
$-0.74 |
| 2018-12-31 |
$-0.75 |
| 2018-09-30 |
$-0.63 |
| 2018-06-30 |
$-0.63 |
| 2018-03-31 |
$-0.58 |
| 2017-12-31 |
$-0.60 |
| 2017-09-30 |
$-0.65 |
| 2017-06-30 |
$-0.77 |
| 2017-03-31 |
$-0.66 |
| 2016-12-31 |
$-0.51 |
| 2016-09-30 |
$-0.55 |
| 2016-06-30 |
$-0.59 |
| 2016-03-31 |
$0.13 |
| 2015-12-31 |
$-0.79 |
| 2015-09-30 |
$-0.36 |
| 2015-06-30 |
$-0.32 |
| 2015-03-31 |
$-0.45 |
| 2014-12-31 |
$-0.56 |
| 2014-09-30 |
$-0.25 |
| 2014-06-30 |
$-0.52 |
| 2014-03-31 |
$-0.30 |
| 2013-12-31 |
$1.43 |
| 2013-09-30 |
$-5.62 |
| 2013-06-30 |
$0.28 |
| 2013-03-31 |
$-0.24 |
| 2012-09-30 |
$-5.82 |
